The Q&A addressed future HPV investments under Gavi 6.0, focusing on Health System Strengthening (HSS) funds, prioritization for HPV, and sustainability beyond 2025. Panelists clarified that current HPV‑specific opportunities should be leveraged now, as the next strategy (2026–2030) may shift toward more flexible health system approaches. The Gates Foundation highlighted ongoing work to identify and vaccinate out‑of‑school girls and share scalable strategies. Coordination among donors, governments, and partners—especially around data, advocacy, and program design—was emphasized to avoid duplication and optimize impact.